Development of Nucleic‐Acid‐Based Electrochemical Biosensors for Clinical Applications
Nucleic acids are remarkable molecules. In addition to Watson–Crick base pairing, the
different structural motifs of these molecules can bind non‐nucleic acid targets or catalyze …
different structural motifs of these molecules can bind non‐nucleic acid targets or catalyze …
Aptamer-based point-of-care diagnostic platforms
A Dhiman, P Kalra, V Bansal, JG Bruno… - Sensors and Actuators B …, 2017 - Elsevier
This review covers a broad range of well-established and novel diagnostic platforms which
are currently being considered for use in commercial point-of care (POC) diagnostics …
are currently being considered for use in commercial point-of care (POC) diagnostics …
A graphene oxide/gold nanoparticle-based amplification method for SERS immunoassay of cardiac troponin I
X Fu, Y Wang, Y Liu, H Liu, L Fu, J Wen, J Li, P Wei… - Analyst, 2019 - pubs.rsc.org
Cardiac troponin I (cTnI) was considered as the “gold standard” for acute myocardial
infarction (AMI) diagnosis owing to its superior cardiac specificity for cardiac damage and …
infarction (AMI) diagnosis owing to its superior cardiac specificity for cardiac damage and …
Recent development of cardiac troponin I detection
Cardiovascular disease (CVD) has threatened human lives for decades, and a technique for
estimating and healing is still needed. There has been increasing interest in finding CVD …
estimating and healing is still needed. There has been increasing interest in finding CVD …
Electrochemical strategies for the detection of cTnI
Acute myocardial infarction (AMI) is the main cause of death from cardiovascular diseases.
Thus, early diagnosis of AMI is essential for the treatment of irreversible damage from …
Thus, early diagnosis of AMI is essential for the treatment of irreversible damage from …
Horseradish peroxidase-triggered direct in situ fluorescent immunoassay platform for sensing cardiac troponin I and SARS-CoV-2 nucleocapsid protein in serum
Direct in situ fluorescent enzyme-linked immunosorbent assay (ELISA) is rarely investigated
and reported. Herein, a direct in situ high-performance HRP-labeled fluorescent …
and reported. Herein, a direct in situ high-performance HRP-labeled fluorescent …
Aptamers targeting cardiac biomarkers as an analytical tool for the diagnostics of cardiovascular diseases: A review
N Komarova, O Panova, A Titov, A Kuznetsov - Biomedicines, 2022 - mdpi.com
The detection of cardiac biomarkers is used for diagnostics, prognostics, and the risk
assessment of cardiovascular diseases. The analysis of cardiac biomarkers is routinely …
assessment of cardiovascular diseases. The analysis of cardiac biomarkers is routinely …
Nanomaterial-based aptasensors as an efficient substitute for cardiovascular disease diagnosis: Future of smart biosensors
As a major cause of deaths in developed countries, cardiovascular disease (CVD) has been
a big burden for human health systems. Its early and rapid detection is crucial to efficiently …
a big burden for human health systems. Its early and rapid detection is crucial to efficiently …
Progress on dot-blot assay as a promising analytical tool: Detection from molecules to cells
In recent years, dot-blot assays have received significant interest in bioanalytical sciences
and shown a significant impact on the identification of a wide variety of target analytes …
and shown a significant impact on the identification of a wide variety of target analytes …
Electrochemical cardiovascular platforms: Current state of the art and beyond
S Szunerits, V Mishyn, I Grabowska… - Biosensors and …, 2019 - Elsevier
Cardiovascular diseases (CVD) remain the leading cause of death within industrialized
nations as well as an increasing cause of mortality and morbidity in many developing …
nations as well as an increasing cause of mortality and morbidity in many developing …